These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25115390)

  • 1. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
    Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
    Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop.
    Fan X; Wang Y; Fan J; Chen R
    J Cell Biochem; 2019 Jun; 120(6):10643-10651. PubMed ID: 30672020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
    Xie D; Gore C; Liu J; Pong RC; Mason R; Hao G; Long M; Kabbani W; Yu L; Zhang H; Chen H; Sun X; Boothman DA; Min W; Hsieh JT
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2485-90. PubMed ID: 20080667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
    Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
    Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
    Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
    Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of DAB2IP in androgen receptor activation during prostate cancer progression.
    Wu K; Liu J; Tseng SF; Gore C; Ning Z; Sharifi N; Fazli L; Gleave M; Kapur P; Xiao G; Sun X; Oz OK; Min W; Alexandrakis G; Yang CR; Hsieh CL; Wu HC; He D; Xie D; Hsieh JT
    Oncogene; 2014 Apr; 33(15):1954-63. PubMed ID: 23604126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of DAB2IP in chemoresistance of prostate cancer cells.
    Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT
    Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.
    Wang B; Huang J; Zhou J; Hui K; Xu S; Fan J; Li L; Wang X; Hsieh JT; He D; Wu K
    Cell Signal; 2016 Nov; 28(11):1623-30. PubMed ID: 27476001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
    Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
    Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
    Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
    PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.
    Arbini AA; Greco M; Yao JL; Bourne P; Marra E; Hsieh JT; di Sant'agnese PA; Moro L
    Am J Pathol; 2011 May; 178(5):2367-76. PubMed ID: 21514447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
    Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
    Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
    Yu L; Tumati V; Tseng SF; Hsu FM; Kim DN; Hong D; Hsieh JT; Jacobs C; Kapur P; Saha D
    Neoplasia; 2012 Dec; 14(12):1203-12. PubMed ID: 23308052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis.
    Zhou J; Ning Z; Wang B; Yun EJ; Zhang T; Pong RC; Fazli L; Gleave M; Zeng J; Fan J; Wang X; Li L; Hsieh JT; He D; Wu K
    Cell Death Dis; 2015 Oct; 6(10):e1955. PubMed ID: 26512963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.
    Xie D; Gore C; Zhou J; Pong RC; Zhang H; Yu L; Vessella RL; Min W; Hsieh JT
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19878-83. PubMed ID: 19903888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.
    Lu W; Liu S; Li B; Xie Y; Adhiambo C; Yang Q; Ballard BR; Nakayama KI; Matusik RJ; Chen Z
    Oncotarget; 2015 Jan; 6(2):771-88. PubMed ID: 25596733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer.
    Samadaian N; Salehipour P; Ayati M; Rakhshani N; Najafi A; Afsharpad M; Yazarlou F; Modarressi MH
    Pathol Res Pract; 2018 Dec; 214(12):2018-2024. PubMed ID: 30301636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
    Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization.
    Chen H; Pong RC; Wang Z; Hsieh JT
    Genomics; 2002 Apr; 79(4):573-81. PubMed ID: 11944990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smurf1 regulation of DAB2IP controls cell proliferation and migration.
    Li X; Dai X; Wan L; Inuzuka H; Sun L; North BJ
    Oncotarget; 2016 May; 7(18):26057-69. PubMed ID: 27036023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.